ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Robert Day Advocates NCI Payment for Investigator Salaries

May 7, 1999

Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief.

December 19, 2008

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years

September 28, 2012

AACR Opposes Human Life Bill; ASCO Backs Cancer Act, Reimbursement

May 8, 1981

Bill Would Harm Pancreatic Cancer Research – Scientists Warn Of Unintended Consequences

August 10, 2012